Pathophysiology of Meningiomas

Brian Ragel; Randy L. Jensen

doi:10.1055/s-2004-817734

RSS-Feed abonnieren

Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.

https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000050.xml

Teilen / Bookmarken

Facebook X Linkedin Weibo

PDF herunterladen

Seminars in Neurosurgery 2003; 14(3): 169-186
DOI: 10.1055/s-2004-817734

Pathophysiology of Meningiomas

Brian Ragel¹ , Randy L. Jensen^1,2,3

¹Department of Neurosurgery, University of Utah, Salt Lake City, Utah
²Neurosurgical Section, Surgical Service, Department of Veterans Affairs (VA), Salt Lake City Health Care System, Salt Lake City, Utah
³Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah

Weitere Informationen

Publikationsverlauf

Publikationsdatum:
02. Juni 2004 (online)

Abstract
Volltext
Referenzen

Artikel einzeln kaufen Lizenzen und Reprints

ABSTRACT

This article provides a brief description of the current knowledge of meningioma tumorigenesis and biology. Meningioma grade, subtyping, histology, and MIB-1 labeling index are discussed in relationship to tumor behavior and recurrence prediction. Chromosomal abnormalities associated with meningioma development are discussed with an emphasis on chromosome 22 and the neurofibromatosis type 2 gene. The current knowledge of prognostic features of 1p deletions is outlined. The role of sex hormones in meningioma growth and development is also discussed and summarized. To date, treatment regimens based on inhibiting hormonally mediated meningioma growth have been disappointing. Research concerning growth factors and peptide hormones that have been implicated in meningioma tumorigenesis is discussed. It is hoped that further understanding of the biology of meningioma development, growth, and angiogenesis will lead to new successful treatments for refractory meningiomas.

KEYWORDS

Meningioma tumorigenesis - tumor grading - histology - prognosis

REFERENCES

1 Al-Rodhan R F, Laws E R. The history of intracranial meningiomas. In: Al-Mefty O, ed. Meningiomas New York: Raven Press 1991: 1-6

Suche in Google Scholar
2 Carroll R S, Zhang J, Black P M. Expression of estrogen receptors alpha and beta in human meningiomas. J Neurooncol . 1999; 42 109-116

Crossref PubMed Suche in Google Scholar
3 Catala M. Embryonic and fetal development of structures associated with the cerebro-spinal fluid in man and other species. Part I: The ventricular system, meninges and choroid plexuses. Arch Anat Cytol Pathol . 1998; 46 153-169

PubMed Suche in Google Scholar
4 Burger P C, Scheithauer B W, Vogel F S. Surgical Pathology of the Nervous System and Its Coverings 4th ed. Philadelphia: Churchill Livingstone; 2002: 49-71

Suche in Google Scholar
5 Osborn A G. Diagnostic Neuroradiology. St. Louis: Mosby 1994: 584-601

Suche in Google Scholar
6 Mahmood A, Caccamo D V, Tomecek F J, Malik G M. Atypical and malignant meningiomas: a clinicopathological review. Neurosurgery . 1993; 33 955-963

PubMed Suche in Google Scholar
7 Gonzales M F. Classification of brain tumors. In: Kaye AH, Laws ER, eds. Brain Tumors 1st ed: Edinburgh: Churchill Livingstone 1995: 675

Suche in Google Scholar
8 Louis D N, Scheithauer B W, Budka H, von Deimling A, Kepes J J. Meningiomas. In: Kleihues P, Cavenee WK, eds. World Health Organization Classification of Tumours: Pathology and Genetics: Tumours of the Nervous System Lyon: IARC Press; 2000: 175-189

Suche in Google Scholar
9 Jaaskelainen J, Haltia M, Servo A. Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol . 1986; 25 233-242

PubMed Suche in Google Scholar
10 Nakasu S, Li D H, Okabe H, Nakajima M, Matsuda M. Significance of MIB-1 staining indices in meningiomas: comparison of two counting methods. Am J Surg Pathol . 2001; 25 472-478

Crossref PubMed Suche in Google Scholar
11 Ho D M, Hsu C Y, Ting L T, Chiang H. Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma. Cancer . 2002; 94 1538-1547

Crossref PubMed Suche in Google Scholar
12 Lanzafame S, Torrisi A, Barbagallo G, Emmanuele C, Alberio N, Albanese V. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up. Pathol Res Pract . 2000; 196 483-488

PubMed Suche in Google Scholar
13 Korshunov A, Shishkina L, Golanov A. DNA topoisomerase II-alpha and cyclin A immunoexpression in meningiomas and its prognostic significance. Arch Pathol Lab Med . 2002; 126 1079-1086

PubMed Suche in Google Scholar
14 Kamei Y, Watanabe M, Nakayama T, Kanamaru K, Waga S, Shiraishi T. Prognostic significance of p53 and p21WAF1/ CIP1 immunoreactivity and tumor micronecrosis for recurrence of meningiomas. J Neurooncol . 2000; 46 205-213

Crossref PubMed Suche in Google Scholar
15 Abramovich C M, Prayson R A. Apoptotic activity and bcl-2 immunoreactivity in meningiomas. Association with grade and outcome. Am J Clin Pathol . 2000; 114 84-92

Crossref PubMed Suche in Google Scholar
16 Bostrom J, Meyer-Puttlitz B, Wolter M. et al . Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Am J Pathol . 2001; 159 661-669

PubMed Suche in Google Scholar
17 Comtesse N, Heckel D, Racz A, Brass N, Glass B, Meese E. Five novel immunogenic antigens in meningioma: cloning, expression analysis, and chromosomal mapping. Clin Cancer Res . 1999; 5 3560-3568

PubMed Suche in Google Scholar
18 Weisberg S, Ashkenazi E, Israel Z. et al . Anaplastic and atypical meningiomas express high levels of Fas and undergo apoptosis in response to Fas ligation. Am J Pathol . 2001; 159 1193-1197

PubMed Suche in Google Scholar
19 Kilic T, Bayri Y, Ozduman K. et al . Tenascin in meningioma: expression is correlated with anaplasia, vascular endothelial growth factor expression, and peritumoral edema but not with tumor border shape. Neurosurgery . 2002; 51 183-193

Crossref PubMed Suche in Google Scholar
20 Griffin C A, Hruban R H, Long P P. et al . Chromosome abnormalities in meningeal neoplasms: do they correlate with histology?. Cancer Genet Cytogenet . 1994; 78 46-52

Crossref PubMed Suche in Google Scholar
21 Bolger G B, Stamberg J, Kirsch I R, Hollis G F, Schwarz D F, Thomas G H. Chromosome translocation t(14;22) and oncogene (c-sis) variant in a pedigree with familial meningioma. N Engl J Med . 1985; 312 564-567

PubMed Suche in Google Scholar
22 Awad I A, Kalfas I, Hahn J F, Little J R. Intracranial meningiomas in the aged: surgical outcome in the era of computed tomography. Neurosurgery . 1989; 24 557-560

PubMed Suche in Google Scholar
23 Cogen P H, Daneshvar L, Bowcock A M, Metzger A K, Cavalli-Sforza L L. Loss of heterozygosity for chromosome 22 DNA sequences in human meningioma. Cancer Genet Cytogenet . 1991; 53 271-277

Crossref PubMed Suche in Google Scholar
24 Casalone R, Minelli E, Granata P, Giudici A. Pseudodicentric isochromosome(22) in meningiomas. Cancer Genet Cytogenet . 1990; 45 273-275

Crossref PubMed Suche in Google Scholar
25 Dumanski J P, Carlbom E, Collins V P, Nordenskjold M. Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma. Proc Natl Acad Sci U S A . 1987; 84 9275-9279

PubMed Suche in Google Scholar
26 Lekanne Deprez H R, Riegman P H, van Drunen E. et al . Cytogenetic, molecular genetic and pathological analyses in 126 meningiomas. J Neuropathol Exp Neurol . 1995; 54 224-235

PubMed Suche in Google Scholar
27 Meese E, Blin N, Zang K D. Loss of heterozygosity and the origin of meningioma. Hum Genet . 1987; 77 349-351

PubMed Suche in Google Scholar
28 Seizinger B R, de la Monte S, Atkins L, Gusella J F, Martuza R L. Molecular genetic approach to human meningioma: loss of genes on chromosome 22. Proc Natl Acad Sci U S A . 1987; 84 5419-5423

PubMed Suche in Google Scholar
29 Zang K D, Singer H. Chromosomal constitution of meningiomas. Nature . 1967; 216 84-85

PubMed Suche in Google Scholar
30 Zankl H, Zang K D. Correlations between clinical and cytogenetical data in 180 human meningiomas. Cancer Genet Cytogenet . 1980; 1 351-356

Crossref PubMed Suche in Google Scholar
31 Zang K D. Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases. Cytogenet Cell Genet . 2001; 93 207-220

Crossref PubMed Suche in Google Scholar
32 Lekanne Deprez H R, Bianchi A B, Groen N A. et al . Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet . 1994; 54 1022-1029

PubMed Suche in Google Scholar
33 Leon S P, Zhu J, Black P M. Genetic aberrations in human brain tumors. Neurosurgery . 1994; 34 708-722

PubMed Suche in Google Scholar
34 Bigner S H, Mark J, Bigner D D. Cytogenetics of human brain tumors. Cancer Genet Cytogenet . 1990; 47 141-154

Crossref PubMed Suche in Google Scholar
35 Wolff R K, Frazer K A, Jackler R K, Lanser M J, Pitts L H, Cox D R. Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors. Am J Hum Genet . 1992; 51 478-485

PubMed Suche in Google Scholar
36 Merel P, Hoang-Xuan K, Sanson M. et al . Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas. Genes Chromosomes Cancer . 1995; 13 211-216

PubMed Suche in Google Scholar
37 Papi L, De Vitis R L, Vitelli F. et al . Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas. Hum Genet . 1995; 95 347-351

PubMed Suche in Google Scholar
38 Ng H K, Lau K M, Tse J Y. et al . Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors. Neurosurgery . 1995; 37 764-773

PubMed Suche in Google Scholar
39 Wellenreuther R, Kraus J A, Lenartz D. et al . Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol . 1995; 146 827-832

PubMed Suche in Google Scholar
40 Ikeda K, Saeki Y, Gonzalez-Agosti C, Ramesh V, Chiocca E A. Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer. J Neurosurg . 1999; 91 85-92

PubMed Suche in Google Scholar
41 Dirven C M, Grill J, Lamfers M L. et al . Gene therapy for meningioma: improved gene delivery with targeted adenoviruses. J Neurosurg . 2002; 97 441-449

PubMed Suche in Google Scholar
42 Lee J H, Sundaram V, Stein D J, Kinney S E, Stacey D W, Golubi M. Reduced expression of schwannomin/merlin in human sporadic meningiomas. Neurosurgery . 1997; 40 578-587

PubMed Suche in Google Scholar
43 Kalamarides M, Niwa-Kawakita M, Leblois H. et al . Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse. Genes Dev . 2002; 16 1060-1065

Crossref PubMed Suche in Google Scholar
44 Akagi K, Kurahashi H, Arita N. et al . Deletion mapping of the long arm of chromosome 22 in human meningiomas. Int J Cancer . 1995; 60 178-182

PubMed Suche in Google Scholar
45 Lekanne Deprez H R, Groen N A, van Biezen A N. et al . A t(4;22) in a meningioma points to the localization of a putative tumor-suppressor gene. Am J Hum Genet . 1991; 48 783-790

PubMed Suche in Google Scholar
46 Lekanne Deprez H R, Groen N A, Louz D. et al . Constitutional DNA-level aberrations in chromosome 22 in a patient with multiple meningiomas. Genes Chromosomes Cancer . 1994; 9 124-128

PubMed Suche in Google Scholar
47 Dumanski J P, Rouleau G A, Nordenskjold M, Collins V P. Molecular genetic analysis of chromosome 22 in 81 cases of meningioma. Cancer Res . 1990; 50 5863-5867

PubMed Suche in Google Scholar
48 Pulst S M, Rouleau G A, Marineau C, Fain P, Sieb J P. Familial meningioma is not allelic to neurofibromatosis 2. Neurology . 1993; 43 2096-2098

PubMed Suche in Google Scholar
49 Schneider G, Lutz S, Henn W, Zang K D, Blin N. Search for putative suppressor genes in meningioma: significance of chromosome 22. Hum Genet . 1992; 88 579-582

PubMed Suche in Google Scholar
50 Ruttledge M H, Sarrazin J, Rangaratnam S. et al . Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet . 1994; 6 180-184

PubMed Suche in Google Scholar
51 Ruttledge M H, Xie Y G, Han F Y. et al . Deletions on chromosome 22 in sporadic meningioma. Genes Chromosomes Cancer . 1994; 10 122-130

PubMed Suche in Google Scholar
52 Bello M J, de Campos M J, Kusak M E. et al . Allelic loss at 1p is associated with tumor progression of meningiomas. Genes Chromosomes Cancer . 1994; 9 296-298

PubMed Suche in Google Scholar
53 Steudel W I, Feld R, Henn W, Zang K D. Correlation between cytogenetic and clinical findings in 215 human meningiomas. Arch Neurochir Suppl (Wien) . 1996; 65 73-76

PubMed Suche in Google Scholar
54 Muller P, Henn W, Niedermayer I. et al . Deletion of chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas. Clin Cancer Res . 1999; 5 3569-3577

PubMed Suche in Google Scholar
55 Henn W, Cremerius U, Heide G. et al . Monosomy 1p is correlated with enhanced in vivo glucose metabolism in meningiomas. Cancer Genet Cytogenet . 1995; 79 144-148

Crossref PubMed Suche in Google Scholar
56 Ketter R, Henn W, Niedermayer I. et al . Predictive value of progression-associated chromosomal aberrations for the prognosis of meningiomas: a retrospective study of 198 cases. J Neurosurg . 2001; 95 601-607

Crossref PubMed Suche in Google Scholar
57 Cai D X, Banerjee R, Scheithauer B W, Lohse C M, Kleinschmidt-Demasters B K, Perry A. Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications. J Neuropathol Exp Neurol . 2001; 60 628-636

PubMed Suche in Google Scholar
58 Lopez-Gines C, Cerda-Nicolas M, Gil-Benso R, Barcia-Salorio J L, Llombart-Bosch A. Loss of 1p in recurrent meningiomas. A comparative study in successive recurrences by cytogenetics and fluorescence in situ hybridization. Cancer Genet Cytogenet . 2001; 125 119-124

Crossref PubMed Suche in Google Scholar
59 Simon M, von Deimling A, Larson J J. et al . Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression. Cancer Res . 1995; 55 4696-4701

PubMed Suche in Google Scholar
60 Schneider B F, Shashi V, von Kap-herr C, Golden W L. Loss of chromosomes 22 and 14 in the malignant progression of meningiomas. A comparative study of fluorescence in situ hybridization (FISH) and standard cytogenetic analysis. Cancer Genet Cytogenet . 1995; 85 101-104

Crossref PubMed Suche in Google Scholar
61 Perry A, Cai D X, Scheithauer B W. et al . Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases. J Neuropathol Exp Neurol . 2000; 59 872-879

PubMed Suche in Google Scholar
62 Gutmann D H, Donahoe J, Perry A. et al . Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas. Hum Mol Genet . 2000; 9 1495-1500

Crossref PubMed Suche in Google Scholar
63 Prempree T, Amornmarn R, Faillace W J, Arce C A, Nguyen T Q. 1;19 translocation in human meningioma. Cancer . 1993; 71 2306-2311

PubMed Suche in Google Scholar
64 Vagner Capodano M A, Grisoli F, Gambarelli D, Sedan R, Pellet W, De Victor B. Correlation between cytogenetic and histopathological findings in 75 human meningiomas. Neurosurgery . 1993; 32 892-900

PubMed Suche in Google Scholar
65 Al Saadi A, Latimer F, Madercic M, Robbins T. Cytogenetic studies of human brain tumors and their clinical significance. II. Meningioma. Cancer Genet Cytogenet . 1987; 26 127-141

Crossref PubMed Suche in Google Scholar
66 Katsuyama J, Papenhausen P R, Herz F, Gazivoda P, Hirano A, Koss L G. Chromosome abnormalities in meningiomas. Cancer Genet Cytogenet . 1986; 22 63-68

Crossref PubMed Suche in Google Scholar
67 Westphal M, Hansel M, Kunzmann R, Holzel F, Herrmann H D. Spectrum of karyotypic aberrations in cultured human meningiomas. Cytogenet Cell Genet . 1989; 52 45-49

PubMed Suche in Google Scholar
68 Bigner S H, Wong A J, Mark J. et al . Relationship between gene amplification and chromosomal deviations in malignant human gliomas. Cancer Genet Cytogenet . 1987; 29 165-170

Crossref PubMed Suche in Google Scholar
69 Mark J. Chromosomal abnormalities and their specificity in human neoplasms: an assessment of recent observations by banding techniques. Adv Cancer Res . 1977; 24 165-222

PubMed Suche in Google Scholar
70 Lopez-Gines C, Cerda-Nicolas M, Barcia-Salorio J L, Llombart-Bosch A. Cytogenetical findings of recurrent meningiomas. A study of 10 tumors. Cancer Genet Cytogenet . 1995; 85 113-117

Crossref PubMed Suche in Google Scholar
71 Pykett M J, Murphy M, Harnish P R, George D L. Identification of a microsatellite instability phenotype in meningiomas. Cancer Res . 1994; 54 6340-6343

PubMed Suche in Google Scholar
72 Cushing J, Eisenhardt L. Meningiomas arising from the tuberculum sella. Arch Ophthalmol . 1929; 1 1-41

PubMed Suche in Google Scholar
73 Bickerstaff E R, Small J M, Guest I A. The relapsing course of certain meningiomas in relation to pregnancy and menstruation. J Neurochem . 1958; 21 89-91

Crossref PubMed Suche in Google Scholar
74 Goldstein P J, Rosenberg S, Smith R W. Maternal death and brain tumor: case report. Am J Obstet Gynecol . 1972; 112 297-298

PubMed Suche in Google Scholar
75 Hagedoorne A. The chiasmal syndrome and retrobulbar neuritis in pregnancy. Am J Ophthalmol . 1937; 20 690-699

PubMed Suche in Google Scholar
76 Weyand A S, Villemure J, Kelly P A. Regulation of DNA synthesis and growth of cells derived from primary human meningiomas. Cancer Res . 1986; 46 2545-2550

PubMed Suche in Google Scholar
77 Mehta D, Khatib R, Patel S. Carcinoma of the breast and meningioma. Association and management. Cancer . 1983; 51 1937-1940

Crossref PubMed Suche in Google Scholar
78 Schoenberg B S, Christine B W, Whisnant J P. Nervous system neoplasms and primary malignancies of other sites. The unique association between meningiomas and breast cancer. Neurology . 1975; 25 705-712

PubMed Suche in Google Scholar
79 Bellur S N, Chandra V, Anderson R J. Association of meningiomas with obesity. Ann Neurol . 1983; 13 346-347

Crossref PubMed Suche in Google Scholar
80 Donnell M S, Meyer G A, Donegan W L. Estrogen-receptor protein in intracranial meningiomas. J Neurosurg . 1979; 50 499-502

PubMed Suche in Google Scholar
81 Magdelenat H, Pertuiset B F, Poisson M. et al . Progestin and oestrogen receptors in meningiomas. Biochemical characterization, clinical and pathological correlations in 42 cases. Acta Neurochir (Wien) . 1982; 64 199-213

Crossref PubMed Suche in Google Scholar
82 Martuza R L, Miller D C, MacLaughlin D T. Estrogen and progestin binding by cytosolic and nuclear fractions of human meningiomas. J Neurosurg . 1985; 62 750-756

PubMed Suche in Google Scholar
83 Poisson M. Sex steroid receptors in human meningiomas. Clin Neuropharmacol . 1984; 7 320-324

PubMed Suche in Google Scholar
84 Tilzer L L, Plapp F V, Evans J P, Stone D, Alward K. Steroid receptor proteins in human meningiomas. Cancer . 1982; 49 633-636

PubMed Suche in Google Scholar
85 Markwalder T M, Zava D T, Goldhirsch A, Markwalder R V. Estrogen and progesterone receptors in meningiomas in relation to clinical and pathologic features. Surg Neurol . 1983; 20 42-47

PubMed Suche in Google Scholar
86 Piantelli M, Rinelli A, Macri E. et al . Type II estrogen binding sites and antiproliferative activity of quercetin in human meningiomas. Cancer . 1993; 71 193-198

PubMed Suche in Google Scholar
87 Blankenstein M A, Blaauw G, Lamberts S W. Progestin and estrogen receptors in human meningioma. Clin Neuropharmacol . 1984; 7 363-367

PubMed Suche in Google Scholar
88 Moguilewsky M, Pertuiset B F, Verzat C, Philibert D, Philippon J, Poisson M. Cytosolic and nuclear sex steroid receptors in meningioma. Clin Neuropharmacol . 1984; 7 375-381

PubMed Suche in Google Scholar
89 Hayward E, Whitwell H, Paul K S, Barnes D M. Steroid receptors in human meningioma. Clin Neuropharmacol . 1984; 7 351-356

PubMed Suche in Google Scholar
90 Cahill D W, Bashirelahi N, Solomon L W, Dalton T, Salcman M, Ducker T B. Estrogen and progesterone receptors in meningiomas. J Neurosurg . 1984; 60 985-993

PubMed Suche in Google Scholar
91 Courriere P, Tremoulet M, Eche N, Armand J P. Hormonal steroid receptors in intracranial tumours and their relevance in hormone therapy. Eur J Cancer Clin Oncol . 1985; 21 711-714

Crossref PubMed Suche in Google Scholar
92 Blaauw G, Blankenstein M A, Lamberts S W. Sex steroid receptors in human meningiomas. Acta Neurochir (Wien) . 1986; 79 42-47

Crossref PubMed Suche in Google Scholar
93 Blankenstein M A, van der Meulen-Dijk C, Thijssen J H. Assay of oestrogen and progestin receptors in human meningioma cytosols using immunological methods. Clin Chim Acta . 1987; 165 189-195

Crossref PubMed Suche in Google Scholar
94 Benzel E C, Gelder F B. Correlation between sex hormone binding and peritumoral edema in intracranial meningiomas. Neurosurgery . 1988; 23 169-174

PubMed Suche in Google Scholar
95 Koehorst S G, Jacobs H M, Tilanus M G, Bouwens A G, Thijssen J H, Blankenstein M A. Aberrant oestrogen receptor species in human meningioma tissue. J Steroid Biochem Mol Biol . 1992; 43 57-61

Crossref PubMed Suche in Google Scholar
96 Brandis A, Mirzai S, Tatagiba M, Walter G F, Samii M, Ostertag H. Immunohistochemical detection of female sex hormone receptors in meningiomas: correlation with clinical and histological features. Neurosurgery . 1993; 33 212-218

Crossref PubMed Suche in Google Scholar
97 Carroll R S, Glowacka D, Dashner K, Black P M. Progesterone receptor expression in meningiomas. Cancer Res . 1993; 53 1312-1316

PubMed Suche in Google Scholar
98 Ironside J W, Battersby R D, Dangerfield V J, Parsons M A, Timperley W R, Underwood J C. Cryostat section assay of oestrogen and progesterone receptors in meningiomas: a clinicopathological study. J Clin Pathol . 1986; 39 44-50

PubMed Suche in Google Scholar
99 Lesch K P, Fahlbusch R. Simultaneous estradiol and progesterone receptor analysis in meningiomas. Surg Neurol . 1986; 26 257-263

PubMed Suche in Google Scholar
100 Lesch K P, Engl H G, Gross S. Androgen receptor binding activity in meningiomas. Surg Neurol . 1987; 28 176-180

PubMed Suche in Google Scholar
101 Lesch K P, Engl H G, Schott W, Gross S. Immunoreactive estrogen receptor protein in meningiomas: comparison with the androgen receptor and progesterone receptor binding activity. Zentralbl Neurochir . 1987; 48 124-134

PubMed Suche in Google Scholar
102 Schrell U M, Adams E F, Fahlbusch R. et al . Hormonal dependency of cerebral meningiomas. Part 1: Female sex steroid receptors and their significance as specific markers for adjuvant medical therapy. J Neurosurg . 1990; 73 743-749

PubMed Suche in Google Scholar
103 Piquer J, Cerda M, Lluch A, Barcia-Salorio J L, Garcia-Conde J. Correlations of female steroid hormone receptors with histologic features in meningiomas. Acta Neurochir (Wien) . 1991; 110 38-43

Crossref PubMed Suche in Google Scholar
104 Meixensberger J, Caffier H, Naumann M, Hofmann E. Sex hormone binding and peritumoural oedema in meningiomas: is there a correlation?. Acta Neurochir (Wien) . 1992; 115 98-102

Crossref PubMed Suche in Google Scholar
105 Perrot-Applanat M, Groyer-Picard M T, Kujas M. Immunocytochemical study of progesterone receptor in human meningioma. Acta Neurochir (Wien) . 1992; 115 20-30

Crossref PubMed Suche in Google Scholar
106 Maxwell M, Galanopoulos T, Neville-Golden J, Antoniades H N. Expression of androgen and progesterone receptors in primary human meningiomas. J Neurosurg . 1993; 78 456-462

PubMed Suche in Google Scholar
107 Verhagen A, Go K G, Visser G M, Blankenstein M A, Vaalburg W. The presence of progesterone receptors in arachnoid granulations and in the lining of arachnoid cysts: its relevance to expression of progesterone receptors in meningiomas. Br J Neurosurg . 1995; 9 47-50

Crossref PubMed Suche in Google Scholar
108 Bouillot P, Pellissier J F, Devictor B. et al . Quantitative imaging of estrogen and progesterone receptors, estrogen-regulated protein, and growth fraction: immunocytochemical assays in 52 meningiomas. Correlation with clinical and morphological data. J Neurosurg . 1994; 81 765-773

PubMed Suche in Google Scholar
109 Zava D T, Markwalder T M, Markwalder R V. Biological expression of steroid hormone receptors in primary meningioma cells in monolayer culture. Clin Neuropharmacol . 1984; 7 382-388

PubMed Suche in Google Scholar
110 Jay J R, MacLaughlin D T, Riley K R, Martuza R L. Modulation of meningioma cell growth by sex steroid hormones in vitro. J Neurosurg . 1985; 62 757-762

PubMed Suche in Google Scholar
111 Olson J J, Beck D W, Schlechte J, Loh P M. Hormonal manipulation of meningiomas in vitro. J Neurosurg . 1986; 65 99-107

PubMed Suche in Google Scholar
112 Weisman A S, Villemure J G, Kelly P A. Regulation of DNA synthesis and growth of cells derived from primary human meningiomas. Cancer Res . 1986; 46 2545-2550

PubMed Suche in Google Scholar
113 Waelti E R, Markwalder T M. Endocrine manipulation of meningiomas with medroxyprogesterone acetate. Effect of MPA on growth of primary meningioma cells in monolayer tissue culture. Surg Neurol . 1989; 31 96-100

PubMed Suche in Google Scholar
114 Grunberg S M, Daniels A M, Muensch H. et al . Correlation of meningioma hormone receptor status with hormone sensitivity in a tumor stem-cell assay. J Neurosurg . 1987; 66 405-408

PubMed Suche in Google Scholar
115 Adams E F, Schrell U M, Fahlbusch R, Thierauf P. Hormonal dependency of cerebral meningiomas. Part 2: In vitro effect of steroids, bromocriptine, and epidermal growth factor on growth of meningiomas. J Neurosurg . 1990; 73 750-755

PubMed Suche in Google Scholar
116 Olson J J, Beck D W, Schlechte J A, Loh P M. Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice. J Neurosurg . 1987; 66 584-587

PubMed Suche in Google Scholar
117 Koper J W, Foekens J A, Braakman R, Lamberts S W. Effects of progesterone on the response to epidermal growth factor and other growth factors in cultured human meningioma cells. Cancer Res . 1990; 50 2604-2607

PubMed Suche in Google Scholar
118 Schrell U M, Nomikos P, Schrauzer T. et al . Hormonal dependency of cerebral meningiomas. Acta Neurochir Suppl (Wien) . 1996; 65 54-57

PubMed Suche in Google Scholar
119 Markwalder T M, Seiler R W. Chronic subdural hematomas: to drain or not to drain?. Neurosurgery . 1985; 16 185-188

PubMed Suche in Google Scholar
120 Goodwin J W, Crowley J, Eyre H J, Stafford B, Jaeckle K A, Townsend J J. A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a Southwest Oncology Group study. J Neurooncol . 1993; 15 75-77

Crossref PubMed Suche in Google Scholar
121 Markwalder T M, Gerber H A, Waelti E, Schaffner T, Markwalder R V. Hormonotherapy of meningiomas with medroxyprogesterone acetate. Immunohistochemical demonstration of the effect of medroxyprogesterone acetate on growth fractions of meningioma cells using the monoclonal antibody Ki-67. Surg Neurol . 1988; 30 97-101

PubMed Suche in Google Scholar
122 Jaaskelainen J, Laasonen E, Karkkainen J, Haltia M, Troupp H. Hormone treatment of meningiomas: lack of response to medroxyprogesterone acetate (MPA). A pilot study of five cases. Acta Neurochir (Wien) . 1986; 80 35-41

Crossref PubMed Suche in Google Scholar
123 Grunberg S M, Weiss M H. Lack of efficacy of megestrol acetate in the treatment of unresectable meningioma. J Neurooncol . 1990; 8 61-65

PubMed Suche in Google Scholar
124 Grunberg S M, Weiss M H, Spitz I M. et al . Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone. J Neurosurg . 1991; 74 861-866

Crossref PubMed Suche in Google Scholar
125 Lamberts S W, Koper J W, de Jong H F. The endocrine effects of long-term treatment with mifepristone (RU 486). J Clin Endocrinol Metab . 1991; 73 187-191

PubMed Suche in Google Scholar
126 Lamberts S W, Koper J W, Reubi J C, Krenning E P. Endocrine aspects of the diagnosis and treatment of primary brain tumours. Clin Endocrinol (Oxf) . 1992; 37 1-10

PubMed Suche in Google Scholar
127 Sartor O, Figg W D. Mifepristone: antineoplastic studies. Clin Obstet Gynecol . 1996; 39 498-505

Crossref PubMed Suche in Google Scholar
128 Piper J G, Follett K A, Fantin A. Sphenoid wing meningioma progression after placement of a subcutaneous progesterone agonist contraceptive implant. Neurosurgery . 1994; 34 723-725

PubMed Suche in Google Scholar
129 Matsuda Y, Kawamoto K, Kiya K, Kurisu K, Sugiyama K, Uozumi T. Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo. J Neurosurg . 1994; 80 527-534

Crossref PubMed Suche in Google Scholar
130 Davis C. Surgical and non-surgical treatment of symptomatic intracranial meningiomas. Br J Neurosurg . 1995; 9 295-302

Crossref PubMed Suche in Google Scholar
131 Carroll R S, Schrell U M, Zhang J. et al . Dopamine D1, dopamine D2, and prolactin receptor messenger ribonucleic acid expression by the polymerase chain reaction in human meningiomas. Neurosurgery . 1996; 38 367-375

PubMed Suche in Google Scholar
132 Jimenez-Hakim E, el Azouzi M, Black P M. The effect of prolactin and bombesin on the growth of meningioma-derived cells in monolayer culture. J Neurooncol . 1993; 16 185-190

Crossref PubMed Suche in Google Scholar
133 Boyle-Walsh E, Shenkin A, White M C, Fraser W D. Effect of glycoprotein and protein hormones on human meningioma cell proliferation in vitro. J Endocrinol . 1995; 145 155-161

PubMed Suche in Google Scholar
134 Smidt M, Kirsch I, Ratner L. Deletion of Alu sequences in the fifth c-sis intron in individuals with meningiomas. J Clin Invest . 1990; 86 1151-1157

PubMed Suche in Google Scholar
135 Kazumoto K, Tamura M, Hoshino H, Yuasa Y. Enhanced expression of the sis and c-myc oncogenes in human meningiomas. J Neurosurg . 1990; 72 786-791

PubMed Suche in Google Scholar
136 Carstens C, Messe E, Zang K D, Blin N. Human KRAS oncogene expression in meningioma. Cancer Lett . 1988; 43 37-41

Crossref PubMed Suche in Google Scholar
137 Diedrich U, Eckermann O, Schmidtke J. Rare Ha-ras and c-mos alleles in patients with intracranial tumors. Neurology . 1988; 38 587-589

PubMed Suche in Google Scholar
138 Detta A, Kenny B G, Smith C, Logan A, Hitchcock E. Correlation of proto-oncogene expression and proliferation and meningiomas. Neurosurgery . 1993; 33 1065-1074

PubMed Suche in Google Scholar
139 Wang G L, Jiang B H, Rue E A, Semenza G L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA . 1995; 92 5510-5514

Crossref PubMed Suche in Google Scholar
140 Zhao J F, Sharma S. Expression of the ROS1 oncogene for tyrosine receptor kinase in adult human meningiomas. Cancer Genet Cytogenet . 1995; 83 148-154

Crossref PubMed Suche in Google Scholar
141 Baugnet-Mahieu L, Lemaire M, Brotchi J. et al . Epidermal growth factor receptors in human tumors of the central nervous system. Anticancer Res . 1990; 10 1275-1280

PubMed Suche in Google Scholar
142 Grimaux M, Magdelenat H, Poisson M. et al . [EGF receptors (epidermal growth factor) and steroid receptors in human meningioma]. Rev Neurol (Paris) . 1988; 144 96-103

PubMed Suche in Google Scholar
143 Diedrich U, Lucius J, Baron E, Behnke J, Pabst B, Zoll B. Distribution of epidermal growth factor receptor gene amplification in brain tumours and correlation to prognosis. J Neurol . 1995; 242 683-688

PubMed Suche in Google Scholar
144 Torp S H, Helseth E, Dalen A, Unsgaard G. Expression of epidermal growth factor receptor in human meningiomas and meningeal tissue. APMIS . 1992; 100 797-802

PubMed Suche in Google Scholar
145 Sanfilippo J S, Rao C V, Guarnaschelli J J. et al . Detection of epidermal growth factor and transforming growth factor alpha protein in meningiomas and other tumors of the central nervous system in human beings. Surg Gynecol Obstet . 1993; 177 488-496

PubMed Suche in Google Scholar
146 Linggood R M, Hsu D W, Efird J T, Pardo F S. TGF alpha expression in meningioma-tumor progression and therapeutic response. J Neurooncol . 1995; 26 45-51

Crossref PubMed Suche in Google Scholar
147 Westphal M, Herrmann H D. Epidermal growth factor-receptors on cultured human meningioma cells. Acta Neurochir (Wien) . 1986; 83 62-66

Crossref PubMed Suche in Google Scholar
148 Koper J W, Zwarthoff E C, Hagemeijer A. et al . Inhibition of the growth of cultured human meningioma cells by recombinant interferon-alpha. Eur J Cancer . 1991; 27 416-419

PubMed Suche in Google Scholar
149 Di Carlo A, Mariano A, Macchia P E, Moroni M C, Beguinot L, Macchia V. Epidermal growth factor receptor in human brain tumors. J Endocrinol Invest . 1992; 15 31-37

PubMed Suche in Google Scholar
150 Kitagawa N, Tsutsumi K, Niwa M. et al . Expression of a functional endothelin (ETA) receptor in human meningiomas. J Neurosurg . 1994; 80 723-731

PubMed Suche in Google Scholar
151 Johnson M D, Horiba M, Winnier A R, Arteaga C L. The epidermal growth factor receptor is associated with phospholipase C-gamma 1 in meningiomas. Hum Pathol . 1994; 25 146-153

Crossref PubMed Suche in Google Scholar
152 Todo T, Fahlbusch R. Accumulation of inositol phosphates in low-passage human meningioma cells following treatment with epidermal growth factor. J Neurosurg . 1994; 80 890-896

PubMed Suche in Google Scholar
153 Carroll R S, Black P M, Zhang J. et al . Expression and activation of epidermal growth factor receptors in meningiomas. J Neurosurg . 1997; 87 315-323

PubMed Suche in Google Scholar
154 Wang J L, Nister M, Hermansson M, Westermark B, Ponten J. Expression of PDGF beta-receptors in human meningioma cells. Int J Cancer . 1990; 46 772-778

PubMed Suche in Google Scholar
155 Adams E F, Todo T, Schrell U M, Thierauf P, White M C, Fahlbusch R. Autocrine control of human meningioma proliferation: secretion of platelet-derived growth-factor-like molecules. Int J Cancer . 1991; 49 398-402

PubMed Suche in Google Scholar
156 Black P M, Carroll R, Glowacka D, Riley K, Dashner K. Platelet-derived growth factor expression and stimulation in human meningiomas. J Neurosurg . 1994; 81 388-393

PubMed Suche in Google Scholar
157 Johnson M D, Woodard A, Kim P, Frexes-Steed M. Evidence for mitogen-associated protein kinase activation and transduction of mitogenic signals by platelet-derived growth factor in human meningioma cells. J Neurosurg . 2001; 94 293-300

Crossref PubMed Suche in Google Scholar
158 Figarella-Branger D, Vagner-Capodano A M, Bouillot P. et al . Platelet-derived growth factor (PDGF) and receptor (PDGFR) expression in human meningiomas: correlations with clinicopathological features and cytogenetic analysis. Neuropathol Appl Neurobiol . 1994; 20 439-447

PubMed Suche in Google Scholar
159 Maxwell M, Galanopoulos T, Hedley-Whyte E T, Black P M, Antoniades H N. Human meningiomas co-express platelet-derived growth factor (PDGF) and PDGF-receptor genes and their protein products. Int J Cancer . 1990; 46 16-21

PubMed Suche in Google Scholar
160 Todo T, Adams E F, Fahlbusch R, Dingermann T, Werner H. Autocrine growth stimulation of human meningioma cells by platelet-derived growth factor. J Neurosurg . 1996; 84 852-859

Crossref PubMed Suche in Google Scholar
161 Schrell U M, Gauer S, Kiesewetter F. et al . Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop. J Neurosurg . 1995; 82 600-607

PubMed Suche in Google Scholar
162 Todo T, Adams E F, Fahlbusch R. Inhibitory effect of trapidil on human meningioma cell proliferation via interruption of autocrine growth stimulation. J Neurosurg . 1993; 78 463-469

PubMed Suche in Google Scholar
163 Jensen R L, Lee Y S, Guijrati M, Origitano T C, Wurster R D, Reichman O H. Inhibition of in vitro meningioma proliferation after growth factor stimulation by calcium channel antagonists: Part II. Additional growth factors, growth factor receptor immunohistochemistry, and intracellular calcium measurements. Neurosurgery . 1995; 37 937-947

PubMed Suche in Google Scholar
164 Jensen R L, Origitano T C, Lee Y S, Weber M, Wurster R D. In vitro growth inhibition of growth factor-stimulated meningioma cells by calcium channel antagonists. Neurosurgery . 1995; 36 365-437

PubMed Suche in Google Scholar
165 Jensen R L, Petr M, Wurster R D. Calcium channel antagonist effect on in vitro meningioma signal transduction pathways after growth factor stimulation. Neurosurgery . 2000; 46 692-703

PubMed Suche in Google Scholar
166 Merry S, Fetherston C A, Kaye S B, Freshney R I, Plumb J A. Resistance of human glioma to adriamycin in vitro: the role of membrane transport and its circumvention with verapamil. Br J Cancer . 1986; 53 129-135

PubMed Suche in Google Scholar
167 Jensen R L, Wurster R D. Calcium channel antagonists inhibit growth of subcutaneous xenograft meningiomas in nude mice. Surg Neurol . 2001; 55 275-283

PubMed Suche in Google Scholar
168 Bowles A P, Pantazis C G, Wansley W. Use of verapamil to enhance the antiproliferative activity of BCNU in human glioma cells: an in vitro and in vivo study. J Neurosurg . 1990; 73 248-253

PubMed Suche in Google Scholar
169 Cano-Gauci D F, Riordan J R. Action of calcium antagonists on multidrug resistant cells. Specific cytotoxicity independent of increased cancer drug accumulation. Biochem Pharmacol . 1987; 36 2115-2123

Crossref PubMed Suche in Google Scholar
170 Helson L. Calcium channel blocker enhancement of anticancer drug cytotoxicity-a review. Cancer Drug Deliv . 1984; 1 353-361

PubMed Suche in Google Scholar
171 Ince P, Appleton D R, Finney K J, Sunter J P, Watson A J. Verapamil increases the sensitivity of primary human colorectal carcinoma tissue to vincristine. Br J Cancer . 1986; 53 137-139

PubMed Suche in Google Scholar
172 Robinson B A, Clutterbuck R D, Millar J L, McElwain T J. Verapamil potentiation of melphalan cytotoxicity and cellular uptake in murine fibrosarcoma and bone marrow. Br J Cancer . 1985; 52 813-822

PubMed Suche in Google Scholar
173 Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res . 1981; 41 1967-1972

PubMed Suche in Google Scholar
174 Takahashi J A, Suzui H, Yasuda Y. et al . Gene expression of fibroblast growth factor receptors in the tissues of human gliomas and meningiomas. Biochem Biophys Res Commun . 1991; 177 1-7

Crossref PubMed Suche in Google Scholar
175 Takahashi J A, Mori H, Fukumoto M. et al . Gene expression of fibroblast growth factors in human gliomas and meningiomas: demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues. Proc Natl Acad Sci USA . 1990; 87 5710-5714

PubMed Suche in Google Scholar
176 Ueba T, Takahashi J A, Fukumoto M. et al . Expression of fibroblast growth factor receptor-1 in human glioma and meningioma tissues. Neurosurgery . 1994; 34 221-226

PubMed Suche in Google Scholar
177 Paulus W, Grothe C, Sensenbrenner M. et al . Localization of basic fibroblast growth factor, a mitogen and angiogenic factor, in human brain tumors. Acta Neuropathol (Berl) . 1990; 79 418-423

Crossref PubMed Suche in Google Scholar
178 Brem S, Tsanaclis A M, Gately S, Gross J L, Herblin W F. Immunolocalization of basic fibroblast growth factor to the microvasculature of human brain tumors. Cancer . 1992; 70 2673-2680

PubMed Suche in Google Scholar
179 Samoto K, Ikezaki K, Ono M. et al . Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res . 1995; 55 1189-1193

PubMed Suche in Google Scholar
180 Antoniades H N, Galanopoulos T, Neville-Golden J, Maxwell M. Expression of insulin-like growth factors I and II and their receptor mRNAs in primary human astrocytomas and meningiomas; in vivo studies using in situ hybridization and immunocytochemistry. Int J Cancer . 1992; 50 215-222

PubMed Suche in Google Scholar
181 Glick R P, Gettleman R, Patel K, Lakshman R, Tsibris J C. Insulin and insulin-like growth factor I in brain tumors: binding and in vitro effects. Neurosurgery . 1989; 24 791-797

PubMed Suche in Google Scholar
182 Glick R P, Unterman T G, Van der Woude M, Blaydes L Z. Insulin and insulin-like growth factors in central nervous system tumors. Part V: Production of insulin-like growth factors I and II in vitro. J Neurosurg . 1992; 77 445-450

PubMed Suche in Google Scholar
183 Lichtor T, Kurpakus M A, Gurney M E. Expression of insulin-like growth factors and their receptors in human meningiomas. J Neurooncol . 1993; 17 183-190

Crossref PubMed Suche in Google Scholar
184 Kurihara M, Tokunaga Y, Tsutsumi K. et al . Characterization of insulin-like growth factor I and epidermal growth factor receptors in meningioma. J Neurosurg . 1989; 71 538-544

PubMed Suche in Google Scholar
185 Unterman T G, Glick R P, Waites G T, Bell S C. Production of insulin-like growth factor-binding proteins by human central nervous system tumors. Cancer Res . 1991; 51 3030-3036

PubMed Suche in Google Scholar
186 Friend K E. Cancer and the potential place for growth hormone receptor antagonist therapy. Growth Horm IGF Res . 2001; 11 (suppl A) S121-S123

PubMed Suche in Google Scholar
187 Tsutsumi K, Kitagawa N, Niwa M, Himeno A, Taniyama K, Shibata S. Effect of suramin on 125I-insulin-like growth factor-I binding to human meningiomas and on proliferation of meningioma cells. J Neurosurg . 1994; 80 502-509

PubMed Suche in Google Scholar
188 Lawrence J H, Tobias C A, Linfoot J A. et al . Successful treatment of acromegaly: metabolic and clinical studies in 145 patients. J Clin Endocrinol Metab . 1970; 31 180-198

PubMed Suche in Google Scholar
189 Khandwala H M, McCutcheon I E, Flyvbjerg A, Friend K E. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev . 2000; 21 215-244

Crossref PubMed Suche in Google Scholar
190 McCutcheon I E, Flyvbjerg A, Hill H. et al . Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice. J Neurosurg . 2001; 94 487-492

PubMed Suche in Google Scholar
191 Trainer P J, Drake W M, Katznelson L. et al . Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med . 2000; 342 1171-1177

Crossref PubMed Suche in Google Scholar
192 van der Lely J A, Hutson R K, Trainer P J. et al . Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet . 2001; 358 1754-1759

Crossref PubMed Suche in Google Scholar
193 Garcia-Luna P P, Relimpio F, Pumar A. et al . Clinical use of octreotide in unresectable meningiomas. A report of three cases. J Neurosurg Sci . 1993; 37 237-241

PubMed Suche in Google Scholar
194 Kunert-Radek J, Stepien H, Radek A, Lyson K, Pawlikowski M. Inhibitory effect of calcium channel blockers on proliferation of human glioma cells in vitro. Acta Neurol Scand . 1989; 79 166-169

PubMed Suche in Google Scholar
195 Huisman T W, Tanghe H L, Koper J W. et al . Progesterone, oestradiol, somatostatin and epidermal growth factor receptors on human meningiomas and their CT characteristics. Eur J Cancer . 1991; 27 1453-1457

PubMed Suche in Google Scholar
196 Reubi J C, Maurer R, von Werder K, Torhorst J, Klijn J G, Lamberts S W. Somatostatin receptors in human endocrine tumors. Cancer Res . 1987; 47 551-558

PubMed Suche in Google Scholar
197 Reubi J C, Horisberger U, Lang W, Koper J W, Braakman R, Lamberts S W. Coincidence of EGF receptors and somatostatin receptors in meningiomas but inverse, differentiation-dependent relationship in glial tumors. Am J Pathol . 1989; 134 337-344

PubMed Suche in Google Scholar
198 Schulz S, Pauli S U, Handel M, Dietzmann K, Firsching R, Hollt V. Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A. Clin Cancer Res . 2000; 6 1865-1874

PubMed Suche in Google Scholar
199 Berkman R A, Merrill M J, Reinhold W C. et al . Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest . 1993; 91 153-159

Crossref PubMed Suche in Google Scholar
200 Hatva E, Kaipainen A, Mentula P. et al . Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J Pathol . 1995; 146 368-378

PubMed Suche in Google Scholar
201 Takano S, Yoshii Y, Kondo S. et al . Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res . 1996; 56 2185-2190

PubMed Suche in Google Scholar
202 Goldman C K, Bharara S, Palmer C A. et al . Brain edema in meningiomas is associated with increased vascular endothelial growth factor expression. Neurosurgery . 1997; 40 1269-1277

PubMed Suche in Google Scholar
203 Kalkanis S N, Carroll R S, Zhang J, Zamani A A, Black P M. Correlation of vascular endothelial growth factor messenger RNA expression with peritumoral vasogenic cerebral edema in meningiomas. J Neurosurg . 1996; 85 1095-1101

PubMed Suche in Google Scholar
204 Provias J, Claffey K, delAguila L, Lau N, Feldkamp M, Guha A. Meningiomas: role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema. Neurosurgery . 1997; 40 1016-1026

PubMed Suche in Google Scholar
205 Lamszus K, Lengler U, Schmidt N O, Stavrou D, Ergun S, Westphal M. Vascular endothelial growth factor, hepatocyte growth factor/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy. Neurosurgery . 2000; 46 938-948

PubMed Suche in Google Scholar
206 Shono T, Inamura T, Torisu M, Suzuki S O, Fukui M. Vascular endothelial growth factor and malignant transformation of a meningioma: case report. Neurol Res . 2000; 22 189-193

PubMed Suche in Google Scholar
207 Dietzmann K, von Bossanyi P, Warich-Kirches M, Kirches E, Synowitz H J, Firsching R. Immunohistochemical detection of vascular growth factors in angiomatous and atypical meningiomas, as well as hemangiopericytomas. Pathol Res Pract . 1997; 193 503-510

PubMed Suche in Google Scholar
208 Nishikawa R, Cheng S Y, Nagashima R, Huang H J, Cavenee W K, Matsutani M. Expression of vascular endothelial growth factor in human brain tumors. Acta Neuropathol (Berl) . 1998; 96 453-462

Crossref PubMed Suche in Google Scholar
209 Pietsch T, Valter M M, Wolf H K. et al . Expression and distribution of vascular endothelial growth factor protein in human brain tumors. Acta Neuropathol (Berl) . 1997; 93 109-117

Crossref PubMed Suche in Google Scholar
210 Yamasaki F, Yoshioka H, Hama S, Sugiyama K, Arita K, Kurisu K. Recurrence of meningiomas. Cancer . 2000; 89 1102-1110

Crossref PubMed Suche in Google Scholar
211 Bitzer M, Opitz H, Popp J. et al . Angiogenesis and brain oedema in intracranial meningiomas: influence of vascular endothelial growth factor. Acta Neurochir (Wien) . 1998; 140 333-340

Crossref PubMed Suche in Google Scholar
212 Yoshioka H, Hama S, Taniguchi E, Sugiyama K, Arita K, Kurisu K. Peritumoral brain edema associated with meningioma: influence of vascular endothelial growth factor expression and vascular blood supply. Cancer . 1999; 85 936-944

Crossref PubMed Suche in Google Scholar
213 Tsai J C, Hsiao Y Y, Teng L J. et al . Regulation of vascular endothelial growth factor secretion in human meningioma cells. J Formos Med Assoc . 1999; 98 111-117

PubMed Suche in Google Scholar
214 Forsythe J A, Jiang B H, Iyer N V. et al . Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol . 1996; 16 4604-4613

PubMed Suche in Google Scholar
215 Richard D E, Berra E, Pouyssegur J. Angiogenesis: how a tumor adapts to hypoxia. Biochem Biophys Res Commun . 1999; 266 718-722

Crossref PubMed Suche in Google Scholar
216 Jensen R L, Soleau S, Bhayani M K, Christiansen D. Expression of hypoxia inducible factor-1 alpha and correlation with preoperative embolization of meningiomas. J Neurosurg . 2002; 97 658-667

PubMed Suche in Google Scholar
217 Pagotto U, Arzberger T, Hopfner U, Weindl A, Stalla G K. Cellular localization of endothelin receptor mRNAs (ETA and ETB) in brain tumors and normal human brain. J Cardiovasc Pharmacol . 1995; 26 (suppl 3) S104-S106

PubMed Suche in Google Scholar
218 Pagotto U, Arzberger T, Hopfner U. et al . Expression and localization of endothelin-1 and endothelin receptors in human meningiomas. Evidence for a role in tumoral growth. J Clin Invest . 1995; 96 2017-2025

PubMed Suche in Google Scholar
219 Harland S P, Kuc R E, Pickard J D, Davenport A P. Characterization of endothelin receptors in human brain cortex, gliomas, and meningiomas. J Cardiovasc Pharmacol . 1995; 26 (suppl 3) S408-S411

PubMed Suche in Google Scholar
220 Yamaga S, Tsutsumi K, Niwa M. et al . Endothelin receptor in microvessels isolated from human meningiomas: quantification with radioluminography. Cell Mol Neurobiol . 1995; 15 327-340

PubMed Suche in Google Scholar
221 Bek E L, McMillen M A. Endothelins are angiogenic. J Cardiovasc Pharmacol . 2000; 36 S135-S139

PubMed Suche in Google Scholar
222 Harland S P, Kuc R E, Pickard J D, Davenport A P. Expression of endothelin(A) receptors in human gliomas and meningiomas, with high affinity for the selective antagonist PD156707. Neurosurgery . 1998; 43 890-899

PubMed Suche in Google Scholar
223 Nitta T, Sato K, Okumura K. Transforming growth factor (TGF)-beta like activity of intracranial meningioma and its effect on cell growth. J Neurol Sci . 1991; 101 19-23

Crossref PubMed Suche in Google Scholar
224 Merlo A, Juretic A, Zuber M. et al . Cytokine gene expression in primary brain tumours, metastases and meningiomas suggests specific transcription patterns. Eur J Cancer . 1993; 29A 2118-2125

PubMed Suche in Google Scholar
225 Johnson M D, Federspiel C F, Gold L I, Moses H L. Transforming growth factor-beta and transforming growth factor beta-receptor expression in human meningioma cells. Am J Pathol . 1992; 141 633-642

PubMed Suche in Google Scholar
226 Johnson M D, Gold L I, Moses H L. Evidence for transforming growth factor-beta expression in human leptomeningeal cells and transforming growth factor-beta-like activity in human cerebrospinal fluid. Lab Invest . 1992; 67 360-368

PubMed Suche in Google Scholar
227 Johnson M D, Jennings M T, Gold L I, Moses H L. Transforming growth factor-beta in neural embryogenesis and neoplasia. Hum Pathol . 1993; 24 457-462

Crossref PubMed Suche in Google Scholar
228 Reubi J C, Lamberts S W, Palacios J M. Hormone dependency of meningiomas. Lancet . 1989; 2 1099-1100

PubMed Suche in Google Scholar
229 Schrell U M, Nomikos P, Fahlbusch R. Presence of dopamine D1 receptors and absence of dopamine D2 receptors in human cerebral meningioma tissue. J Neurosurg . 1992; 77 288-294

PubMed Suche in Google Scholar
230 Todo T, Adams E F, Rafferty B, Fahlbusch R, Dingermann T, Werner H. Secretion of interleukin-6 by human meningioma cells: possible autocrine inhibitory regulation of neoplastic cell growth. J Neurosurg . 1994; 81 394-401

PubMed Suche in Google Scholar
231 Levy E I, Paino J E, Sarin P S. et al . Enzyme-linked immunosorbent assay quantification of cytokine concentrations in human meningiomas. Neurosurgery . 1996; 39 823-829

PubMed Suche in Google Scholar
232 Boyle-Walsh E, Hashim I A, Speirs V, Fraser W D, White M C. Interleukin-6 (IL-6) production and cell growth of cultured human ameningiomas: interactions with interleukin-1 beta (IL-1 beta) and interleukin-4 (IL-4) in vitro. Neurosci Lett . 1994; 170 129-132

Crossref PubMed Suche in Google Scholar
233 Huttner A, Lei T, Fahlbusch R, Schrell W, Adams E F. Relationship between cAMP induced inhibition of human meningioma cell proliferation and autocrine secretion of interleukin-6. Life Sci . 1996; 58 1323-1329

Crossref PubMed Suche in Google Scholar
234 Folkman J, Ingber D. Inhibition of angiogenesis. Semin Cancer Biol . 1992; 3 89-96

PubMed Suche in Google Scholar
235 Kaba S E, DeMonte F, Bruner J M. et al . The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B. Neurosurgery . 1997; 40 271-275

Crossref PubMed Suche in Google Scholar
236 Zhang Z J, Muhr C, Wang J L. Interferon-alpha inhibits the DNA synthesis induced by PDGF and EGF in cultured meningioma cells. Anticancer Res. 16 717-723

PubMed
237 Wober-Bingol C, Wober C, Marosi C, Prayer D. Interferon-alfa-2b for meningioma. Lancet . 1995; 345 331

PubMed Suche in Google Scholar
238 Muhr C, Gudjonsson O, Lilja A, Hartman M, Zhang Z J, Langstrom B. Meningioma treated with interferon-alpha, evaluated with [(11)C]-L-methionine positron emission tomography. Clin Cancer Res . 2001; 7 2269-2276

PubMed Suche in Google Scholar
239 Gibelli N, Zibera C, Butti G. et al . Hormonal modulation of brain tumour growth: a cell culture study. Acta Neurochir (Wien) . 1989; 101 129-133

Crossref PubMed Suche in Google Scholar
240 Lee L S, Chi C W, Chang T J, Chou M D, Liu H C, Liu T Y. Steroid hormone receptors in meningiomas of Chinese patients. Neurosurgery . 1989; 25 541-545

PubMed Suche in Google Scholar
241 Yu Z Y, Wrange O, Boethius J, Hatam A, Granholm L, Gustafsson J A. A study of glucocorticoid receptors in intracranial tumors. J Neurosurg . 1981; 55 757-760

PubMed Suche in Google Scholar
242 Carroll R S, Zhang J, Dashner K, Sar M, Wilson E M, Black P M. Androgen receptor expression in meningiomas. J Neurosurg . 1995; 82 453-460

PubMed Suche in Google Scholar
243 Mailleux P, Przedborski S, Beaumont A. et al . Neurotensin high affinity binding sites and endopeptidase 24.11 are present respectively in the meningothelial and in the fibroblastic components of human meningiomas. Peptides . 1990; 11 1245-1253

Crossref PubMed Suche in Google Scholar
244 Przedborski S, Levivier M, Cadet J L. Neurotensin receptors in human meningiomas. Ann Neurol . 1991; 30 650-654

Crossref PubMed Suche in Google Scholar
245 Recht L, Torres C O, Smith T W, Raso V, Griffin T W. Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy. J Neurosurg . 1990; 72 941-945

PubMed Suche in Google Scholar
246 Battaini F, Leggio A, Govoni S. et al . Decrease in phorbol ester receptors in human brain tumors. Eur Neurol . 1990; 30 241-246

PubMed Suche in Google Scholar
247 Rudling M J, Angelin B, Peterson C O, Collins V P. Low density lipoprotein receptor activity in human intracranial tumors and its relation to the cholesterol requirement. Cancer Res . 1990; 50 483-487

PubMed Suche in Google Scholar
248 Sawaya R, Yamamoto M, Ramo O J, Shi M L, Rayford A, Rao J S. Plasminogen activator inhibitor-1 in brain tumors: relation to malignancy and necrosis. Neurosurgery . 1995; 36 375-381

PubMed Suche in Google Scholar
249 Shinoura N, Heffelfinger S C, Miller M. et al . RNA expression of complement regulatory proteins in human brain tumors. Cancer Lett . 1994; 86 143-149

Crossref PubMed Suche in Google Scholar
250 Figarella-Branger D, Pellissier J F, Bouillot P. et al . Expression of neural cell-adhesion molecule isoforms and epithelial cadherin adhesion molecules in 47 human meningiomas: correlation with clinical and morphological data. Mod Pathol . 1994; 7 752-761

PubMed Suche in Google Scholar
251 Yamashima T, Sakuda K, Tohma Y. et al . Prostaglandin D synthase (beta-trace) in human arachnoid and meningioma cells: roles as a cell marker or in cerebrospinal fluid absorption, tumorigenesis, and calcification process. J Neurosci . 1997; 17 2376-2382

PubMed Suche in Google Scholar